secwatch.observer — SEC 8-K summary
======================================

Issuer:     LABCORP HOLDINGS INC. (LH)
CIK:        0000920148
Form:       8-K
Filed at:   2026-09-10T20:47:55+00:00
Accession:  0000920148-26-000201
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Labcorp Investor Day: 5-8% revenue CAGR through 2029, reaffirms 2026 guidance
-----------------------------------------------------------------------------

- Reaffirms 2026 guidance: revenue $14.71-14.83B (5.4-6.3% growth), adjusted EPS $18.10-18.55, FCF $1.24-1.36B.
- Long-term outlook through 2029: 5-8% compound annual revenue growth, 8.5-11.5% adjusted EPS CAGR.
- Targets 75-150 bps adjusted operating margin expansion by end of 2029; FCF growth in line with adjusted earnings.
- Strategic priorities: specialty testing (oncology, neurology, autoimmune, women's health), health-system partnerships, AI/robotics.
- CEO Adam Schechter cites above-market growth expectation; CFO Julia Wang details disciplined capital deployment framework.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/920148/000092014826000201/0000920148-26-000201-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/920148/000092014826000201/lh-20260910.htm
  HTML page:      https://secwatch.observer/filing/0000920148-26-000201

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer